4.6 Article

Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action

Journal

MOLECULAR NEUROBIOLOGY
Volume 55, Issue 7, Pages 5490-5504

Publisher

SPRINGER
DOI: 10.1007/s12035-017-0782-1

Keywords

Mastoparan; Glioblastoma; Cationic peptide; Necrosis; Phosphatidylserine

Categories

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [2012/02065-0, 2016/13368-4, 2012/50336-2]
  2. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [477780/2010-5]
  3. Capes
  4. CNPq [142066/2014-1]
  5. Fapesp [2009/53840-0]
  6. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/53840-0] Funding Source: FAPESP

Ask authors/readers for more resources

Glioblastoma multiforme is the most common and lethal malignant brain tumor. Because of its complexity and heterogeneity, this tumor has become resistant to conventional therapies and the available treatment produces multiple side effects. Here, using multiple experimental approaches, we demonstrate that three mastoparan peptides-Polybia-MP1, Mastoparan X, and HR1-from solitary wasp venom exhibit potent anticancer activity toward human glioblastoma multiforme cells. Importantly, the antiglioblastoma action of mastoparan peptides occurs by membranolytic activity, leading to necrosis. Our data also suggest a direct relation between mastoparan membranolytic potency and the presence of negatively charged phospholipids like phosphatidylserine. Collectively, these data may warrant additional studies for mastoparan peptides as new agents for the treatment of glioblastoma multiforme brain tumor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available